Media stories about Xylem (NYSE:XYL) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Xylem earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the industrial products company an impact score of 46.9033952149954 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news articles that may have impacted Accern’s analysis:
- Hot Stock’s Alert – Xylem Inc (NYSE: XYL) (stockspen.com)
- Attractive Stock of Thursday — Xylem Inc. (XYL) (stockmarketstop.com)
- Clues to Identify Stock Value – Xylem Inc. (NYSE:XYL) (nasdaqjournal.com)
- Extremely Informative stocks: Xylem Inc., (NYSE: XYL), New Relic, Inc., (NYSE: NEWR) (globalexportlines.com)
- Xylem highlights commitment to global sustainability in annual Sustainability Report (proudgreenbuilding.com)
NYSE:XYL opened at $66.45 on Monday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.02 and a current ratio of 1.42. Xylem has a one year low of $53.78 and a one year high of $79.83. The company has a market cap of $11.97 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 1.28 and a beta of 1.10.
The company also recently declared a quarterly dividend, which was paid on Thursday, June 21st. Stockholders of record on Thursday, May 24th were given a $0.21 dividend. The ex-dividend date was Wednesday, May 23rd. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.26%. Xylem’s dividend payout ratio (DPR) is currently 35.00%.
XYL has been the topic of several recent research reports. Cowen reiterated a “buy” rating and set a $80.00 target price on shares of Xylem in a research report on Tuesday, March 6th. Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Thursday, March 22nd. Stifel Nicolaus cut their target price on shares of Xylem from $77.00 to $75.00 and set a “hold” rating on the stock in a research report on Wednesday, May 2nd. Canaccord Genuity set a $78.00 target price on shares of Xylem and gave the stock a “hold” rating in a research report on Tuesday, April 24th. Finally, Oppenheimer reiterated a “buy” rating and set a $82.00 target price on shares of Xylem in a research report on Tuesday, May 1st. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Xylem presently has a consensus rating of “Buy” and a consensus price target of $80.20.
In other news, Director Curtis J. Crawford sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, May 14th. The shares were sold at an average price of $73.39, for a total value of $550,425.00. Following the transaction, the director now owns 41,744 shares in the company, valued at approximately $3,063,592.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.81% of the stock is currently owned by insiders.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.